abstract |
The present invention relates to a method and kit for the production of monoclonal anitbodies using B cell stimulatory agent(s), such as antiCEACAM antibody and LPS. Furthermone, the invention relates to use of CEACAM for B cell stimulation in for example immunotherapy. |